Pharmaceutical trademarks must be selected carefully, as patient safety is at stake. Prescription errors due to similarities between trademarks must be minimised. In Germany, the Federal Institute for Drugs and Medical Devices is the competent authority within the Federal Ministry of Health to authorise medicinal products on the basis of the Medicines Act.


Unlock unlimited access to all WTR content